CG
Chad Gassert
SVP - Corp. Dev. & Strategy

Chad Gassert insider trades: Ani Pharmaceuticals (ANIP) stock buys and sales

SVP - Corp. Dev. & Strategy, Ani Pharmaceuticals Last trade Nov 13, 2025 20 Form 4 filings
$1.3M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2022
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Chad reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 13, 2025ANIP↓ Sell$1.3M
Aug 15, 2025ANIP↓ Sell$1.7M
Jul 1, 2024ANIP↓ Sell$1.3M
Jun 3, 2024ANIP↓ Sell$1.3M
May 1, 2024ANIP↓ Sell$1.3M
Apr 1, 2024ANIP↓ Sell$1.3M
Mar 11, 2024ANIP↓ Sell$1.3M
Oct 2, 2023ANIP↓ Sell$1.1M
Sep 1, 2023ANIP↓ Sell$1.3M
Aug 1, 2023ANIP↓ Sell$1.0M
Jul 3, 2023ANIP↓ Sell$1.1M
Jun 22, 2023ANIP↓ Sell$1.0M
Mar 21, 2022ANIP↑ Buy$275K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ANIP insiders

Open-market trades in the last 12 months

About Chad Gassert's insider trades

Chad Gassert is SVP - Corp. Dev. & Strategy at Ani Pharmaceuticals (ANIP). Since Mar 21, 2022, Chad has reported 1 open-market purchase worth $275K and 12 sales worth $15.1M on SEC Form 4. In the last 12 months: 1 sale ($1.3M).

Their filings also include grants and awards (5 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.